Tubero Tablet 30/10 mg (Pimasartan Potassium, Rosuvastatin)

Adult dose

1. Pimasartan The recommended dosage of this medication is 30 to 60 mg once daily, administered regardless of meals. If blood pressure is not adequately controlled, the dosage may be increased to 120 mg once daily. It is recommended to take it at the same time each day (e.g. morning). 2. Rosuvastatin The initial dosage is 5 mg once daily, and for cases requiring greater reduction of LDL-cholesterol levels, it can be adjusted to a maintenance dose.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to the ingredients of this medication, women who are pregnant or may become pregnant, nursing mothers, and women of childbearing age who are not using appropriate contraception should not take this medication. This medication should not be used in patients with moderate to severe liver impairment, patients with bile duct obstruction, patients with muscle disorders, patients with severe renal impairment, and patients taking certain medications. Patients with low blood volume or sodium, patients with impaired kidney function, and patients with heart valve disease should be especially cautious when taking this medication and adjust the dosage under physician supervision. This medication can cause serious muscle-related side effects such as myalgia or myopathy, and rarely rhabdomyolysis, so if symptoms of muscle pain or weakness occur, patients should inform medical personnel immediately. Additionally, this medication may affect liver function, so it is important to have regular liver function tests before and during the course of treatment. There may be interactions with other medications, so if the patient is taking current medications, they must inform their healthcare provider, especially when taken with potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc. There may be symptoms such as dizziness or drowsiness when driving or operating machinery, so caution is advised. This medication has not been established for safety and efficacy in children and adolescents under 18, so it is advisable not to use it in this population. In case of overdose, appropriate treatment based on symptoms is necessary, and especially symptoms of hypotension or liver function abnormalities may occur, so patients should consult medical personnel immediately. Finally, this medication should be stored out of reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues with cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Headache
• dizziness
• nausea
• vomiting
• dyspepsia
• abdominal pain
• fever
• itching
• myalgia
• arthralgia

Store this medication in a tightly sealed container to prevent air or moisture from entering, and keep it at room temperature, between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance

Light green, convex, octagonal film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP packaging × 3], 100 tablets/box [10 tablets/PTP packaging × 10], 30 tablets/box [10 tablets/Alu-Alu packaging × 3], 100 tablets/box [10 tablets/Alu-Alu packaging × 10]